4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-015731
SVP, Business Development sold 12,529 shares at an average $19.96 ($250,092)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Birznieks Gunther SVP, Business Development | 2019-03-01 | Sale | −3,741 | $20.14 | $75,325 | 160,039 | D: show line 1 in the form |
| Birznieks Gunther SVP, Business Development | 2019-03-04 | Sale | −8,788 | $19.89 | $174,767 | 151,251 | D: show line 2 in the form |
| Open-market sales · 12,529 sh · avg $19.96 · $250,092 | |||||||
Loading xslF345X03/doc4.xml…